Here we go again.
The folks at Wachtell, Lipton, Rosen & Katz are relaunching an old offensive against activist fund managers.
The New York law firm — a longtime specialist in takeover defense strategies and the widely credited inventor of the poison pill — last week fired off a new eight-page letter once again calling for reforming the rules governing filings of 13D forms with the Securities and Exchange Commission.
